Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-11 Purchase |
2022-03-15 5:01 pm |
Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer |
40,000 | $8.4712 | $338,850 | 42,333 (Direct) |
View |
| 2022-02-11 Purchase |
2022-02-15 9:51 pm |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director |
195,700 | $10.17 | $1,989,446 | 4,043,629 (Indirect) |
View |
| 2022-02-11 Purchase |
2022-02-15 9:42 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director |
195,700 | $10.17 | $1,989,446 | 4,043,629 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Tax Withholding |
2023-03-03 5:56 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
1,721 | $5.21 | 67,378 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:54 pm |
N/A 2033-03-01 |
Kinnate Biopharma Inc. | KNTE | DeSimone Jill Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-23 2:16 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
550,000 | $0 | 4,593,629 (Indirect) |
View |
Ownership |
2023-02-23 1:58 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd Director 10% Owner |
0 | $0 | 1,100,000 (Indirect) |
View |
| 2023-02-17 Option Award |
2023-02-22 4:30 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
550,000 | $0 | 4,593,629 (Indirect) |
View |
| 2023-02-17 Other |
2023-02-22 2:50 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
1,100,000 | $0 | 13,038,311 (Indirect) |
View |
| 2023-02-17 Other |
2023-02-22 2:49 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner |
1,100,000 | $0 | 13,038,311 (Indirect) |
View |
| 2023-02-10 Option Award(A) |
2023-02-15 11:01 am |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 5:00 pm |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
215,000 | $0 | 215,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 5:00 pm |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer |
215,000 | $0 | 215,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 5:00 pm |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer |
750,000 | $0 | 215,000 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 5:00 pm |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
215,000 | $0 | 215,000 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-02 8:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer |
541 | $7.75 | 67,933 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-02 8:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
1,459 | $7.75 | 69,099 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-02 8:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
541 | $7.75 | 27,924 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer |
25,000 | $0 | 68,474 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
67,500 | $0 | 69,015 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
25,000 | $0 | 28,465 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:01 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | Sabzevari Helen Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:01 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:00 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | MITCHELL DEAN J Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:00 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:00 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:00 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | Rome Michael E Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:00 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | Smaldone Alsup Laurie Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:00 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | Epperly Melissa B Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:01 pm |
N/A 2032-02-11 |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:01 pm |
N/A 2032-02-11 |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
185,000 | $0 | 185,000 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:00 pm |
N/A 2032-02-11 |
Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:00 pm |
N/A 2032-02-11 |
Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 1:04 pm |
N/A 2031-06-24 |
Kinnate Biopharma Inc. | KNTE | Sabzevari Helen Director |
40,501 | $0 | 40,501 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-14 8:20 pm |
N/A 2031-06-11 |
Kinnate Biopharma Inc. | KNTE | MITCHELL DEAN J Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-14 7:15 pm |
N/A 2031-06-11 |
Kinnate Biopharma Inc. | KNTE | Smaldone Alsup Laurie Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-14 7:13 pm |
N/A 2031-06-11 |
Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-14 7:13 pm |
N/A 2031-06-11 |
Kinnate Biopharma Inc. | KNTE | Epperly Melissa B Director |
20,250 | $0 | 20,250 (Direct) |
View |